Ursodeoxycholic acid in serum and liver tissue in patients with end-stage cholestatic liver cirrhosis.
Kita
Y
Y
Department of Surgery, University of Tokyo, Japan.
Sakakura
H
H
Hirata
M
M
Harihara
Y
Y
Tanaka
H
H
Ito
M
M
Yoshino
H
H
Takayama
T
T
Kubota
K
K
Hashizume
K
K
Makuuchi
M
M
D000293:Adolescent; D000328:Adult; D016738:Alagille Syndrome / Q000378:metabolism; D001647:Bile Acids and Salts / Q000097:blood / Q000378:metabolism*; D001656:Biliary Atresia / Q000188:drug therapy / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008099:Liver / Q000378:metabolism*; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy / Q000378:metabolism*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use*
D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid